“Management of Infants with NAS, Therapeutic Interventions” (Part 2 of 2)
Event Navigation
As part of its Neonatal Education Series 2018, Saxe Communications and Philips Healthcare present a Neonatal Abstinence Syndrome (NAS) Webinars Series
(See also: Part 1: “Assessment of Infants With NAS” [offered Feb. 21, 2018])
“Management of Infants with NAS, Therapeutic Interventions” (Part 2 of 2)
Wed., May 2, 2018, 11AM – 12PM (Central)
Neonatal Abstinence Syndrome (NAS) can be potentially severe and cause long hospital stays. Pharmacological interventions are commonly used as treatment and their safety and efficacy is continuing to be studied. Non-pharmacologic interventions and complementary therapies have also been documented. This presentation will discuss the pharmacologic and non-pharmacologic goals of treating infants with NAS. There will also be a discussion of the most common drugs used to manage signs of withdrawal and two different strategies, weight based vs sign based, to determine when pharmacologic treatment is needed. Additionally, nurse-driven interventions including swaddling, kangaroo care, low stimuli and breastfeeding will also be discussed.
Learning Objectives
After the completion of this activity, the participant will be able to:
- Identify the goal of pharmacologic and non-pharmacologic treatment of NAS.
- Discuss the nurse-driven interventions (non-pharmacologic) to support the infant with NAS.
- Describe two different strategies for treating infants with NAS pharmacologically.
Presenter:
Karen D’Apolito, PhD, NNP-BC, FAAN l Director, Neonatal NP Specialty l Vanderbilt University School of Nursing
Continuing Education for Nurses: This education activity is approved for 1.0 contact hour. Saxe Healthcare Communications is accredited as a provider for continuing education by the California Board of Nursing Provider #14477 and the Florida Board of Nursing Provider # 50-17032.
Educational support has been provided by Philips Healthcare
